Table 3.

Odds Ratios for Ordinal Logistic Regression Model for Predicting Graded Anemia Event as Determined by Division of AIDS Criteria

 Univariable Multivariable 
CharacteristicOR95% CIAICOR95% CIAIC
Baseline hemoglobin0.399.296–.522253.60.379.276–.505233.5
Linezolid area under the time-concentration curve over 24 hours at steady state1.0111.006–1.016262.21.0121.007–1.017
Duration of linezolid1.0021.001–1.003293.4
Female sex1.650.813–3.392304.4
Age1.0921.023–1.169299.3
Weight-for-age z score0.811.526–1.212308.3
Dose above current recommendationsa5.4292.223–13.632292.6
 Univariable Multivariable 
CharacteristicOR95% CIAICOR95% CIAIC
Baseline hemoglobin0.399.296–.522253.60.379.276–.505233.5
Linezolid area under the time-concentration curve over 24 hours at steady state1.0111.006–1.016262.21.0121.007–1.017
Duration of linezolid1.0021.001–1.003293.4
Female sex1.650.813–3.392304.4
Age1.0921.023–1.169299.3
Weight-for-age z score0.811.526–1.212308.3
Dose above current recommendationsa5.4292.223–13.632292.6

Abbreviations: AIC, Akaike’s information criterion; CI, confidence interval; OR, odds ratio.

The empty cells under the multivariable section are for those variables not included in the final multivariable model.

aGiven dose recommendations changed after the development of the initial population pharmacokinetic model. Some of the data that were collected prior to current recommendations contained doses above what is currently recommended and were evaluated in the ordinal logistic regression model.

Table 3.

Odds Ratios for Ordinal Logistic Regression Model for Predicting Graded Anemia Event as Determined by Division of AIDS Criteria

 Univariable Multivariable 
CharacteristicOR95% CIAICOR95% CIAIC
Baseline hemoglobin0.399.296–.522253.60.379.276–.505233.5
Linezolid area under the time-concentration curve over 24 hours at steady state1.0111.006–1.016262.21.0121.007–1.017
Duration of linezolid1.0021.001–1.003293.4
Female sex1.650.813–3.392304.4
Age1.0921.023–1.169299.3
Weight-for-age z score0.811.526–1.212308.3
Dose above current recommendationsa5.4292.223–13.632292.6
 Univariable Multivariable 
CharacteristicOR95% CIAICOR95% CIAIC
Baseline hemoglobin0.399.296–.522253.60.379.276–.505233.5
Linezolid area under the time-concentration curve over 24 hours at steady state1.0111.006–1.016262.21.0121.007–1.017
Duration of linezolid1.0021.001–1.003293.4
Female sex1.650.813–3.392304.4
Age1.0921.023–1.169299.3
Weight-for-age z score0.811.526–1.212308.3
Dose above current recommendationsa5.4292.223–13.632292.6

Abbreviations: AIC, Akaike’s information criterion; CI, confidence interval; OR, odds ratio.

The empty cells under the multivariable section are for those variables not included in the final multivariable model.

aGiven dose recommendations changed after the development of the initial population pharmacokinetic model. Some of the data that were collected prior to current recommendations contained doses above what is currently recommended and were evaluated in the ordinal logistic regression model.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close